Preparation of ganglioside ELISA plates Reconstitute the ganglioside vials with 1 ml of chloroform/methanol (1:1), except in the case of GQ1b, which is reconstituted with…
Objective: To detect PMP-2 in serum samples of GBS patients and see if the concentration is detectable and different from healthy controls. ELISA PMP-2 Kit…
Objective:To test serum NfL in patients with IGLON5 encephalitis (5 serum and 1 CSF) and GBS patients (baseline and different timepoints). MATERIALS: Bead reagent Detector…
Objective: To test if we can use the ELISA to detect serum NfL levels in GBS patients. This ELISA is valided to be used only…
Objective: To investigate Monkey’s Peripheral nerve IHC for IgG staining paterns of Guillain-Barré patients after SARS-CoV-2 infection with NCAM Ab, a colocalization with NCAM commercial mAb. Samples:…
Objective: To investigate Monkey’s Peripheral nerve IHC for IgM staining paterns of Guillain-Barré patients after SARS-CoV-2 infection with NCAM Ab, a colocalization with NCAM commercial mAb. Samples:…
Objective: To detect antibodies against NF155, nodal neurofascins (NF140, NF186) and CNTN1. Samples: 21-2-0768, 21-2-0769, 21-2-0770, 21-2-0771, 21-2-0772, 21-2-0773, 21-2-0774, 21-2-0775, 21-2-0776. Immunocytochemistry for CNTN1:…
Objective: CASPR1 antibodies screening in Guillain-Barré patients after SARS-CoV-2 infection. Samples: 21-2-0768, 21-2-0769, 21-2-0770, 21-2-0771, 21-2-0772, 21-2-0773, 21-2-0774, 21-2-0775, 21-2-0776. Materials: Maxisorb 96-well ELISA plates…
Samples: IgG: IGOS 26-28, 30-33, 35-49 CNTN1/CASPR1 patients CIDP78, 17-595, 19-205, 16-047, 20-2, 20-1, R, Vieira, Piffort, 19-216 Negative control Positive control (15-198) IgM: IGOS…
Samples: IgG: IGOS 0-29 (no 2, 14, 18, 25) Negative control Positive control (15-198) IgM: IGOS 0-29 (no 2, 14, 18, 25) Negative control DRG…